BamSEC and AlphaSense Join Forces
Learn More

Pelthos Therapeutics Inc. – Articles of Incorporation

NYSE American: PTHS    
Share price (3/26/26): $22.74    
Market cap (3/26/26): $76.3 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.4
from 10-Q 4 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.4
from 8-K 11 pages Bylaws of Pelthos Therapeutics Inc., a Nevada Corporation
12/34/56
EX-3.3
from 8-K 35 pages Work Order Number: W2025070101488 Reference Number: 20255006039 Through Date: 7/1/2025 1:17:06 Pm Corporate Name: Pelthos Therapeutics Inc. the Undersigned Filing Officer Hereby Certifies That the Attached Copies Are True and Exact Copies of All Requested Statements and Related Subsequent Documentation Filed With the Secretary of State’s Office, Commercial Recordings Division Listed on the Attached Report. Document Number Description Number of Pages 20255005941 Certificate of Designation 34 Respectfully, Francisco V. Aguilar Nevada Secretary of State
12/34/56
EX-3.2
from 8-K 3 pages Work Order Number: W2025070101488 Reference Number: 20255006039 Through Date: 7/1/2025 1:17:15 Pm Corporate Name: Pelthos Therapeutics Inc. the Undersigned Filing Officer Hereby Certifies That the Attached Copies Are True and Exact Copies of All Requested Statements and Related Subsequent Documentation Filed With the Secretary of State’s Office, Commercial Recordings Division Listed on the Attached Report. Document Number Description Number of Pages 20255006030 Certificate Pursuant to Nrs 78.209 1 Respectfully, Francisco V. Aguilar Nevada Secretary of State
12/34/56
EX-3.1
from 8-K 6 pages Work Order Item Number: W2025070101488-4556036 Filing Number: 20255006017 Filing Type: Amendment After Issuance of Stock Filing Date/Time: 7/1/2025 12:38:00 Pm Filing Page(s): 3 Indexed Entity Information: Entity Id: E42848462024-4 Entity Name: Pelthos Therapeutics Inc. Entity Status: Active Expiration Date: None Commercial Registered Agent Nevada Agency and Transfer Company
12/34/56
EX-3.1
from 8-K 31 pages Form of Certificate of Designations of Rights and Preferences of Series a Convertible Preferred Stock of Channel Therapeutics Corporation Under Section 78.1955 of the Nevada Revised Statues
12/34/56
EX-3.1II
from 8-K12G3 12 pages Bylaws of Channel Therapeutics Corporation, a Nevada Corporation
12/34/56
EX-3.1IC
from 8-K12G3 14 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street Certificate of Designation of Series C Convertible Redeemable Preferred Stock of Channel Therapeutics Corporation Pursuant to Section 78.1955 of the Nevada Revised Statutes
12/34/56
EX-3.1IB
from 8-K12G3 2 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street
12/34/56
EX-3.1IA
from 8-K12G3 17 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street
12/34/56
EX-3.1II
from 8-K 12 pages Bylaws of Channel Therapeutics Corporation, a Nevada Corporation
12/34/56
EX-3.1IC
from 8-K 14 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street Certificate of Designation of Series C Convertible Redeemable Preferred Stock of Channel Therapeutics Corporation Pursuant to Section 78.1955 of the Nevada Revised Statutes
12/34/56
EX-3.1IB
from 8-K 2 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street
12/34/56
EX-3.1IA
from 8-K 17 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street
12/34/56
EX-3.3
from 10-K 13 pages Certificate of Designation of Series C Convertible Redeemable Preferred Stock of Chromocell Therapeutics Corporation
12/34/56
EX-3.2
from 8-K 24 pages Amended and Restated By-Laws of Chromocell Therapeutics Corporation
12/34/56
EX-3.1
from 8-K 8 pages Amended and Restated Certificate Incorporation of Chromocell Therapeutics Corporation I
12/34/56
EX-3.5
from S-1/A 12 pages Certificate of Designation of Series C Convertible Redeemable Preferred Stock of Chromocell Therapeutics Corporation
12/34/56
EX-3.4
from S-1/A 29 pages Certificate of Designations, Preferences and Rights of the Series B Convertible Preferred Stock of Chromocell Therapeutics Corporation
12/34/56
EX-3.5
from S-1/A 13 pages Certificate of Designation of Series C Convertible Redeemable Preferred Stock of Chromocell Therapeutics Corporation
12/34/56